Nephrocare Health Services (NSE: NEPHROPLUS)

Clinics/Outpatient Services · Hyderabad, India · Founded 2009 · Publicly Held

Nephrocare Health Services Ltd is a dialysis services provider company. Nephrocare Health Services (NSE: NEPHROPLUS) is based in Hyderabad, India and was founded in 2009. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $515 million (Dec 2025). It has raised $267 million across 1 recorded round; the latest was a $103 million Series F in May 2024.

Last price · $/share
—
Implied valuation
$514.5M
Total raised
$267.3M
Last round
Later Stage VC (Series F)
May 2024
No prints on record

No secondary trades in Nephrocare Health Services (NSE: NEPHROPLUS) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nephrocare Health Services (NSE: NEPHROPLUS) with a free account
  • ·Watch Nephrocare Health Services (NSE: NEPHROPLUS): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where Nephrocare Health Services (NSE: NEPHROPLUS) prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Nephrocare Health Services (NSE: NEPHROPLUS) stock.